MedTrace Logo

The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules

NCT03790735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-01-02

No results posted yet for this study

Summary

* The purpose of the study is the identification of the efficacy of MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules.
* In this study, the investigators are going to validate the efficacy of the MDA test for diagnosing early lung cancer by comparing results of the pre-surgery MDA test with the post-surgery pathology.

Conditions

  • Pulmonary Nodule, Solitary

Interventions

DIAGNOSTIC_TEST

FISH

Targeted chromosomal aberrations detection

Sponsors & Collaborators

  • Zhuhai livzon cynvenio diagnostics LTD

    collaborator UNKNOWN

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • Changli Wang, Prof · Tianjin Medical University Cancer Institute and Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2019-03-31
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03790735 on ClinicalTrials.gov